Results 251 to 260 of about 39,319 (333)

Evaluation of Bruton's Tyrosine Kinase (BTK) inhibition with alternative doses of ibrutinib in subjects with Chronic Lymphocytic Leukemia (CLL). [PDF]

Cancer Chemother Pharmacol
Ouerdani A, Valenzuela B, Treijtel N, Haddish-Berhane N, Desphande S, Srinivasan S, Smith E, Perez Ruixo JJ.   +7 more
europepmc   +1 more source

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia [PDF]

, 2015
Aymerich, Marta, Campo, Elías, Colomer, Dolors, Lagisetti, Chandraiah, López Guerra, Mónica, López Otín, Carlos, Montraveta, Arnau, Rodríguez, Vanina, Roldán, Jocabed, Rosich, Laia, Villamor Casas, Neus, Webb, Thomas R., Xargay-Torrent, Sçilvia   +12 more
core   +1 more source

Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas. [PDF]

Blood Adv
Chihara D, Steiner RE, Nair R, Feng L, Ahmed S, Strati P, Malpica L, Griffith DP, Mathew SA, Montinez W, Masand G, Samaniego F, Rodriguez MA, Hagemeister FB, Fayad LE, Iyer SP, Nastoupil LJ, Neelapu SS, Flowers CR, Westin JR.   +19 more
europepmc   +1 more source

Predicting the risk of ibrutinib in combination with R-ICE in patients with relapsed or refractory DLBCL using explainable machine learning algorithms. [PDF]

Clin Exp Med
Zhu N, Shen RB, Chen JF, Gu JY, Xiang SC, Zhang Y, Qian LL, Guo Q, Chen SN, Shen JP, Yan J, Xiang JJ.   +11 more
europepmc   +1 more source

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance) [PDF]

, 2018
Fehniger, Todd A.
core   +1 more source

Real world results of ibrutinib in patients with relapsed or refractory chronic lymphocytic leukemia: a meta-analysis of clinical studies. [PDF]

BMC Pharmacol Toxicol
Karimi MA, Norooziseyedhosseini H, Khademi R, Ghajary A, Kargar H, Abdollahi SS, Belbasi M, Naziri M, Deravi N, Hajihosseini S, Mofidi S.   +10 more
europepmc   +1 more source

Invasive aspergillosis related to ibrutinib therapy for chronic lymphocytic leukemia

, 2017
Benjamin J. Arthurs, Kathy Wunderle, Maylee Hsu, Suil Kim   +3 more
openalex   +1 more source

Cardiotoxicity of small-molecule kinase inhibitors in cancer therapy. [PDF]

Exp Hematol Oncol
Zhu S, Fu K, Li S, Yang C, Pan C, Wang X, Wang F, Yu X, To KKW, Fu L.   +9 more
europepmc   +1 more source

Ibrutinib-induced pyoderma gangrenosum

Polish Archives of Internal Medicine, 2016
Andrzej Mital, Aleksandra Wilkowska, Wioletta Barańska-Rybak, Roman Nowicki, Michał Sobjanek, Martyna Sławińska   +5 more
openaire   +3 more sources